SI-BONE To Present at BofA Securities 2022 Healthcare Conference
SI-BONE, Inc. (Nasdaq: SIBN) will participate in the 2022 Bank of America Healthcare Conference in Las Vegas, hosting a fireside chat presentation on May 11, 2022, at 12:40 PM PT / 3:40 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SI-BONE, Inc. (Nasdaq: SIBN) will participate in the 2022 Bank of America Healthcare Conference in Las Vegas, hosting a fireside chat presentation on May 11, 2022, at 12:40 PM PT / 3:40 PM ET. A live webcast and archived recording will be accessible on the company's website for 90 days post-event.
SI-BONE specializes in surgical treatments for musculoskeletal disorders, particularly with its iFuse Implant System, which addresses SI joint pain, responsible for 15%-30% of chronic low back pain. More than 65,000 procedures have been performed using this system.
Details
News Market Reaction – SIBN
The recorded move for SIBN in the trading session of this news was +9.38%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2022 Bank of America Healthcare Conference in Las Vegas. Management will be hosting a fireside chat presentation on Wednesday, May 11th, 2022, at 12:40 p.m. Pacific Time / 3:40 p.m. Eastern Time.
A live webcast of each event, as well as an archived recording will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcasts will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. In 2009, SI-BONE introduced the iFuse Implant System for minimally invasive surgery of the SI joint, shown to be a source of pain in
For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.
SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc. ©2022 SI-BONE, Inc. All Rights Reserved.
Investor Contact:
Matt Bacso, CFA
investors@SI-BONE.com
Media Contact:
Joe Powers
jpowers@si-bone.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.